Rizvi N, Antonia S, Callahan MK, et al. Impact of Tumor Mutation Burden on the Efficacy of Nivolumab or Nivolumab + Ipilimumab in Small Cell Lung Cancer: An Exploratory Analysis of CheckMate 032. 18th World Conference on Lung Cancer (WCLC) 2017, abstract OA 07.03a.
Neoadjuvant dostarlimab bij mismatch repair-deficiënte tumoren
jul 2025 | Gynaecologische oncologie, Immuuntherapie, Maag-darm-leveroncologie, Uro-oncologie